Metabolica Health

Metabolica Health is a development-stage biotechnology company focused on discovering and developing novel therapies for diabetes and obesity. The company collaborates with leading global universities, emphasizing the use of products, derivatives, and mechanisms related to the metabolism of the gut microbiome. Metabolica Health's innovative approach is highlighted by its valuable intellectual property portfolio in this field. With the global type 2 diabetes treatment market expected to reach $77.2 billion by 2027, growing at a compound annual growth rate (CAGR) of 6.6% from 2022 to 2027, Metabolica Health is at the forefront of addressing this significant global health challenge.